Coherence Neuro Raises $45M, Taps Founders Fund And OpenAI Fund
Coherence Neuro raised a $45 million Series A co-led by Founders Fund and The OpenAI Startup Fund to develop an implantable device built on electrical biomarkers of cancer.
Company intelligence
As of October 28, 2026, Coherence Neuro has raised at least $45M in equity across 1 sourced funding round.
Is something wrong on this page?
| Date | Round | Amount | Valuation | Lead investors | Source |
|---|---|---|---|---|---|
| Oct 28, 2026 | Series A | $45M | — | Founders Fundunverified WithLux Capitalunverified8VCunverifiedBlackbird VenturesunverifiedPossible VenturesunverifiedDivergent CapitalunverifiedThe OpenAI Startup FundTimelessOlive CapitalAhren+4 more | ITBrief |
Equity only. “Equity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.
Coherence Neuro has raised at least $45M in equity across 1 sourced funding round tracked by Value Add VC. The most recent was a $45M Series A in October 2026, reported by ITBrief. Debt financing, tender offers and secondary sales are not counted.
Lead investors in Coherence Neuro's sourced funding rounds include Founders Fund. Per round: its October 2026 Series A was led by Founders Fund.
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.